NA-911

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameNA-911
Drug Alias NameNA-911
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsInsulin-like growth factor I stimulants
TargetsGlucagon-like peptide 1 receptorInsulin-like growth factor I
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiomed Industries Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiomed Industries Inc
Inactive CompaniesN/A
Active IndicationsStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A